HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

474.473

+5.3621.14%

Number of Gainers:21

Number of Losers:24

Number of Flat:6

PE:- -

High:475.049

Open:468.227

Low:465.418

Close:469.111

Volume:311.67M

Turnover:9.25B

Market Cap:2.97T

Float Cap:2.09T

Loading ...

Morgan Stanley Trims China Resources Beer Target to HK$30, Maintains Overweight Stance

Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call

BofA Securities Adjusts Fuyao Glass Price Target While Retaining Buy Stance

Daiwa Raises KEYMED BIO-B Price Target to HK$110, Reaffirming Buy Call

Blue Moon Group Holdings (SEHK:6993), What Is Behind The Latest Move?

Simply Wall St.

Peijia Medical (SEHK:9996) Stock Nears Breakeven As Revenue Momentum Builds

Simply Wall St.

Antengene (SEHK:6996) Stock Drops As Profit Arrives And Valuation Looms

Simply Wall St.

Jinxin Fertility Group (SEHK:1951) Stock Price Reflects Calm Despite Profit Rebound

Simply Wall St.

China Tower (SEHK:788) Reports Stronger Half Year Earnings, Is The Stock Cheap?

Simply Wall St.

Asset Managers Raised Long Positions in 5-Year and 10-Year Treasury Futures Prior to Expanded Buyback Announcement

Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

Jinxin Fertility Group Insider Ups Holding By 42% During Year

Simply Wall St.

Asset Managers Boost 5-Year and 10-Year Treasury Futures Positions Before Buyback Expansion Announcement

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

PEIJIA-B Reports 20.1% Revenue Growth in Interim Results

Peijia Medical H1 FY26 Loss Narrows 87.4% to RMB 8.99 Million; Revenue Rises 20.1% to RMB 424.5 Million

Edding Genor Group Expects Revenue of Rmb850 MLN-Rmb900 MLN for HY

Edding Genor Expects H1 Net Loss of RMB 60 Million-RMB 70 Million vs Year-Ago Profit

Jhbp Cy - Expects Revenue of Rmb850 Mln-Rmb900 Mln for Six Months Ended 30 June 2026

THOMSON REUTERS

Simcere Pharmaceutical Group (SEHK:2096) Stock Price Trails Margin Surge And DCF Gap

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK1583/news?page=21"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":474.47263,"timestamp":1788334336745,"preClose":469.11102,"halted":0,"volume":311668534,"delay":0,"changeRate":0.011429,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.361603,"latestTime":"09-02 15:32:16","open":468.22687,"high":475.04938,"low":465.4181,"amount":9247702074,"amplitude":0.020531,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788336600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"pbRate":2.123393,"peRate":44.857386,"turnoverRate":0.003034,"increases":21,"decrements":24,"flats":4,"marketCap":2971938205088,"floatMarketCap":2086818389984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":475.04938,"amplitude":0.020531,"preClose":469.11102,"low":465.4181,"pbRate":"2.123393","latestPrice":474.47263,"volume":311668534,"delay":0,"open":468.22687,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":483.092,"twentyDayClose":476.028,"sixtyDayClose":414.418,"secType":"PLATE","market":"HK","turnoverRate":0.003034,"peRate":44.857386,"marketCap":2971938205088,"floatMarketCap":2086818389984,"timestamp":1788334336745,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":21,"down":24,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:21,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184537276","title":"Morgan Stanley Trims China Resources Beer Target to HK$30, Maintains Overweight Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1184537276","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184537276?lang=en_us&edition=fundamental","pubTime":"2026-08-23 13:01","pubTimestamp":1787461272,"startTime":"0","endTime":"0","summary":"Morgan Stanley has released a research report adjusting its price target for CHINA RES BEER (00291) downward from HK$35 to HK$30, while keeping an \"Overweight\" rating intact.Based on the first-half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","IE0008369823.USD","IE00B0169L03.USD","IE00B031HY20.USD","LU1023057109.AUD","IE00B5MMRT66.SGD","BK1570","LU1794554557.SGD","SG9999006514.SGD","BK1604","BK1510","BK1578","LU0359201612.USD","LU0328353924.USD","IE00B543WZ88.USD","BK1583","80291","LU1720050803.USD","LU1769817096.USD","IE0031814852.USD","00291","LU0359202008.SGD","IE00B29SXG58.USD","EWH","LU1769817179.HKD","CRHKY","BK1521","BK1180","IE0008368742.USD","LU1328615791.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143799433","title":"Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1143799433","media":"Deep News","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143799433?lang=en_us&edition=fundamental","pubTime":"2026-08-23 12:50","pubTimestamp":1787460624,"startTime":"0","endTime":"0","summary":"Citi has released a research report stating that KEYMED BIO-B (02162) posted first-half 2026 revenue of RMB 617 million, up 24% year-on-year. Within that total, sales of stapokibart reached RMB 393...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU0203345920.USD","LU0130102774.USD","BK1587","C","EWH","IE00BSNM7G36.USD","LU0130517989.USD","LU0310800965.SGD","LU0203347892.USD","LU1244550494.USD","LU1506573853.SGD","LU1244550221.USD","LU2360032135.SGD","LU1162221912.USD","LU1366192091.USD","LU0098860793.USD","LU0052756011.USD","LU0072461881.USD","02162","LU1074936037.SGD","BK1583","TFNS","LU2125154778.USD","LU0106831901.USD","LU2417539215.USD","LU2125154935.USD","BK4588","BK4559","LU0162691827.USD","LU0320765646.SGD","BK4585","LU1244550577.SGD","LU1791807156.HKD","LU2456880835.USD","BK4566","BK1161","LU1144417596.USD","LU1668664300.SGD","IYF","LU0128525689.USD","LU0170899867.USD","LU0980610538.SGD","LU1267930227.SGD","LU2236285917.USD","LU1201861249.SGD","LU0314106906.USD","LU2462157665.USD","BK4504","LU0477156953.USD","BK4534","FTXO","LU0648001328.SGD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136783904","title":"BofA Securities Adjusts Fuyao Glass Price Target While Retaining Buy Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1136783904","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136783904?lang=en_us&edition=fundamental","pubTime":"2026-08-23 12:45","pubTimestamp":1787460330,"startTime":"0","endTime":"0","summary":"BofA Securities has released a research note indicating that Fuyao Glass (03606) generated revenue of RMB 11.6 billion in the second quarter of 2026, essentially flat year-on-year but up 11%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","BK0235","LU0455707207.USD","LU1048588211.SGD","LU2362541273.HKD","LU2177674079.SGD","LU0828238088.HKD","161027","LU0516422952.EUR","LU1146622755.USD","LU2213484517.USD","BK0187","SGXZ81163826.USD","LU0072462343.USD","LU0972618739.USD","03606","LU1655091616.SGD","BK0175","LU0502904849.HKD","LU1242518931.SGD","BK1583","BK0015","600660","BK1509","IE0008368742.USD","LU0269904917.USD","BK1594","BK0028","LU0516422440.USD","LU0979878070.USD","LU1171460220.USD","LU2279858448.HKD","LU1781817850.SGD","LU1064131003.USD","BK0196","BK1144","IE00B031HY20.USD","LU0051755006.USD","LU1785774172.SGD","LU2148510915.USD","BK0188","BK1554","LU0327786744.USD","LU0516423174.USD","LU0509642566.USD","LU0516422366.SGD","LU1064130708.USD","SGXZ49509284.SGD","LU0516423091.SGD","LU2362540622.SGD","LU2008162690.USD","BK0183","LU2362541513.USD","EWH","LU1242518857.USD","LU2242644610.SGD","IE0034224299.USD","IE0008369823.USD","LU1580142542.USD","LU0572944931.SGD","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174192289","title":"Daiwa Raises KEYMED BIO-B Price Target to HK$110, Reaffirming Buy Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1174192289","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174192289?lang=en_us&edition=fundamental","pubTime":"2026-08-23 12:40","pubTimestamp":1787460029,"startTime":"0","endTime":"0","summary":"Daiwa has released a research report stating that KEYMED BIO-B (02162) 2026 first-half results broadly aligned with its previous profit alert and the firm's estimates. Management has raised the 2026...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02162","BK1587","BK1583","BK1574","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661621704","title":"Blue Moon Group Holdings (SEHK:6993), What Is Behind The Latest Move?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661621704","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661621704?lang=en_us&edition=fundamental","pubTime":"2026-08-23 10:24","pubTimestamp":1787451871,"startTime":"0","endTime":"0","summary":"Earnings trigger for Blue Moon Group Holdings stock\nBlue Moon Group Holdings (SEHK:6993) recently reported half year 2026 results that combined weaker sales with a smaller net loss. This earnings update is an important reference point for how the stock is viewed.\nSee our latest analysis for Blue Moon Group Holdings.\nThe latest half year results appear to have supported improving sentiment around Blue Moon Group Holdings, with a 1-day share price return of 2.47% and a year-to-date share price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5211000-choice2-main-header/1585186858909","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5211000-choice2-main-header/1585186858909"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/household/hkg-6993/blue-moon-group-holdings-shares/news/blue-moon-group-holdings-sehk6993-what-is-behind-the-latest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/household/hkg-6993/blue-moon-group-holdings-shares/news/blue-moon-group-holdings-sehk6993-what-is-behind-the-latest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06993","BK1583","DCF","BK1102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217313","title":"Peijia Medical (SEHK:9996) Stock Nears Breakeven As Revenue Momentum Builds","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217313","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217313?lang=en_us&edition=fundamental","pubTime":"2026-08-23 07:18","pubTimestamp":1787440688,"startTime":"0","endTime":"0","summary":"Peijia Medical stock closed at HK$4.98 on the day of its H1 2026 release after a choppy few months that left the 90 day return in decline. The market came in focused on whether the company could keep shrinking losses while still pushing top line growth in high end cardiovascular devices.\nThe headline is that Peijia Medical is selling more while bleeding far less. Revenue for H1 2026 reached ¥424.5m, while the net loss narrowed sharply to ¥7.6m. For long term investors in this still...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-9996/peijia-medical-shares/news/peijia-medical-sehk9996-stock-nears-breakeven-as-revenue-mom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-9996/peijia-medical-shares/news/peijia-medical-sehk9996-stock-nears-breakeven-as-revenue-mom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1100","09996","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212911","title":"Antengene (SEHK:6996) Stock Drops As Profit Arrives And Valuation Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212911?lang=en_us&edition=fundamental","pubTime":"2026-08-23 04:28","pubTimestamp":1787430511,"startTime":"0","endTime":"0","summary":"The market has spent the past week marking Antengene lower, with the stock down about 10% over seven days, yet the latest numbers tell a very different story. H1 2026 landed with a sharp swing into profit, with basic earnings per share at ¥0.34 and net income of ¥216.345 million on revenue of ¥513.076 million. For a high P/E stock trading at about 42.4x trailing earnings, this move into the black is the headline. The key question now is whether this profitability burst can justify that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6996/antengene-shares/news/antengene-sehk6996-stock-drops-as-profit-arrives-and-valuati","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6996/antengene-shares/news/antengene-sehk6996-stock-drops-as-profit-arrives-and-valuati","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","JOYT","RGLO","BK1191","FEBU","PMDE","BK1583","VGFPF","DECU","BK1574","06996","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661125612","title":"Jinxin Fertility Group (SEHK:1951) Stock Price Reflects Calm Despite Profit Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2661125612","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661125612?lang=en_us&edition=fundamental","pubTime":"2026-08-23 04:19","pubTimestamp":1787429942,"startTime":"0","endTime":"0","summary":"Jinxin Fertility Group stock closed at HK$2.23 on the day of its H1 2026 results, capping a flat month but a slightly positive week. The market look is calm. The earnings story is not. The headline is a clean return to profit, with basic earnings per share back in positive territory and net income from ongoing operations in the black for the trailing year. The key question for you is whether that profitability shift is being treated as routine, when it directly contrasts with the heavy loss...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1951/jinxin-fertility-group-shares/news/jinxin-fertility-group-sehk1951-stock-price-reflects-calm-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1951/jinxin-fertility-group-shares/news/jinxin-fertility-group-sehk1951-stock-price-reflects-calm-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1597","01951","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216002","title":"China Tower (SEHK:788) Reports Stronger Half Year Earnings, Is The Stock Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216002","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661216002?lang=en_us&edition=fundamental","pubTime":"2026-08-22 16:16","pubTimestamp":1787386597,"startTime":"0","endTime":"0","summary":"China Tower (SEHK:788) recently reported half year 2026 results and announced an interim cash dividend, giving investors fresh information on both earnings and shareholder payouts ahead of key September and October dates.\nSee our latest analysis for China Tower.\nDespite the interim dividend and stronger half year earnings, China Tower's share price return has been mixed, with the stock up 1.63% over the last day but down 19.95% year to date. The 3 year total shareholder return of 36.74%...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/telecom/hkg-788/china-tower-shares/news/china-tower-sehk788-reports-stronger-half-year-earnings-is-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/telecom/hkg-788/china-tower-shares/news/china-tower-sehk788-reports-stronger-half-year-earnings-is-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0823413587.USD","PMDE","BK1133","VOTE","BK1506","IE00BHRH8C09.USD","DECU","RGLO","IE00BG0RBZ43.SGD","BK1589","FEBU","LU0823413660.USD","GXDW","JOYT","BK1583","VGFPF","BK1529","BK1521","00788","IE00BHRH8D16.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175733860","title":"Asset Managers Raised Long Positions in 5-Year and 10-Year Treasury Futures Prior to Expanded Buyback Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1175733860","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175733860?lang=en_us&edition=fundamental","pubTime":"2026-08-22 08:55","pubTimestamp":1787360159,"startTime":"0","endTime":"0","summary":"Data from the Commodity Futures Trading Commission (CFTC) reveals that asset managers increased their net long exposure in select US Treasury futures contracts before the Treasury Department's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WAMA","TYO","ZNmain","MUNX","BBIB","ZBmain","BK1229","BBLB","LQDU","UFIV","TLTW","BK4550","BK4561","SCHO","BBSB","BK4504","VGIT","HYGD","TMF","IEI","IGOV","HYGU","BK1583","BITC","PFI","TLH","UBmain","BSV","HMOP","BOXX","VCIT","BIL","SHY","AGG","IEF","GBIL","BWX","DBND","USHY","MTNmain","SGOV","VGSH","TBT","TLTX","TBJL","MUB","USVN","BK4535","TLT","ISHG","TNmain","BK4585","09983","TLTI","BNDW","HYG","TSYW","UTRE","VGLT","LQD","BND","BOND","MINT","JPST","CIVG","TFJL","BK1542","MYCN","ZROZ","UTWY","LIAJ","AMGR","MWNmain","BK4588","TIP","SHV","BK1258","NGHT","GOVT","BK4581","TBIL","UTHY","XBIL","ZFmain","FGBXmain","BWZ","FLGV","LQDD","GOLY","UBT","VCSH","GABF","EDV","ZTmain","ADVX","TRUF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661215890","title":"Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2661215890","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661215890?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:01","pubTimestamp":1787353294,"startTime":"0","endTime":"0","summary":"Investors in Keymed Biosciences Inc. ( HKG:2162 ) had a good week, as its shares rose 2.8% to close at HK$80.30...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-inc-just-missed-earnings-but-analysts-hav","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-inc-just-missed-earnings-but-analysts-hav","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","BK1587","02162","RGLO","BK1161","GXDW","BK1574","VGFPF","JOYT","DECU","FEBU","BK1583","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661215845","title":"Jinxin Fertility Group Insider Ups Holding By 42% During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2661215845","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661215845?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:23","pubTimestamp":1787350998,"startTime":"0","endTime":"0","summary":"Looking at Jinxin Fertility Group Limited's ( HKG:1951 ) insider transactions over the last year, we can see that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1951/jinxin-fertility-group-shares/news/jinxin-fertility-group-insider-ups-holding-by-42-during-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1951/jinxin-fertility-group-shares/news/jinxin-fertility-group-insider-ups-holding-by-42-during-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1597","BK1219","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151774385","title":"Asset Managers Boost 5-Year and 10-Year Treasury Futures Positions Before Buyback Expansion Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1151774385","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151774385?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:17","pubTimestamp":1787350643,"startTime":"0","endTime":"0","summary":"Data from the U.S. Commodity Futures Trading Commission (CFTC) reveals that asset managers increased their net long exposure in select U.S. Treasury futures contracts prior to the Treasury...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISHG","MWNmain","TLTW","HYGU","TMF","GABF","BK4535","IEI","ADVX","WAMA","LQDU","TYO","TBT","BK4561","BK4504","AMGR","VCSH","FGBXmain","UTWY","UBmain","BK4588","XBIL","VGIT","BND","BSV","09983","BOXX","TIP","SHV","UTRE","HMOP","ZNmain","LIAJ","TLH","VGLT","MUB","IEF","SGOV","FLGV","BK1542","JPST","BBIB","UBT","MUNX","TSYW","TNmain","DBND","BNDW","BWZ","PFI","USVN","ZTmain","UTHY","TRUF","EDV","CIVG","BBSB","AGG","BIL","HYG","TBIL","TFJL","MINT","BK1229","BOND","VCIT","BITC","TBJL","GOLY","BK4550","UFIV","GBIL","BK1258","USHY","ZBmain","ZFmain","LQD","ZROZ","NGHT","SCHO","BBLB","HYGD","MTNmain","BK4581","SHY","IGOV","GOVT","TLTX","BK1583","TLTI","VGSH","TLT","BK4585","LQDD","MYCN","BWX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661901362","title":"Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2661901362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661901362?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:15","pubTimestamp":1787346928,"startTime":"0","endTime":"0","summary":"Niki BioSolutionsweighs financing options as going-concern warning clouds post-merger outlookOverviewUS biopharmaceutical developer's H1 net loss widened, with loss per share at $1.6Operating expenses","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","BK4139","BK1587","NIKI","HK0000165453.HKD","BK1574","IE00BZ08YR35.GBP","BK1583","IE00BZ08YS42.EUR","BK1161","BK1521","BK1589","BK1191","06996","IE00BZ08YT58.USD","BK1515","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126074349","title":"PEIJIA-B Reports 20.1% Revenue Growth in Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1126074349","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126074349?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:18","pubTimestamp":1787321897,"startTime":"0","endTime":"0","summary":"PEIJIA-B (09996) has announced its interim results for 2026, with revenue reaching RMB 425 million, representing a year-on-year increase of 20.1%. Gross profit climbed 17.13% to RMB 290 million,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","BK1100","BK1583","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295247","title":"Peijia Medical H1 FY26 Loss Narrows 87.4% to RMB 8.99 Million; Revenue Rises 20.1% to RMB 424.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295247","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:08","pubTimestamp":1787321303,"startTime":"0","endTime":"0","summary":"Peijia Medical H1 FY26 loss narrows 87.4% to RMB 8.99 million; revenue rises 20.1% to RMB 424.5 millionPeijia Medical posted revenue of RMB 424.5 million, up 20.1% year over year, in the six months en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL97k65j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729592","title":"Edding Genor Group Expects Revenue of Rmb850 MLN-Rmb900 MLN for HY","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729592","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729592?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:59","pubTimestamp":1787320752,"startTime":"0","endTime":"0","summary":"BRIEF-Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HYAug 21 (Reuters)-Edding Genor Group Holdings Ltd6998.HK:EXPECTS REVENUE OF RMB850 MILLION-RMB900 MILLION FOR SIX MONTHS ENDED 30 JUNE 2026Further company coverage:6998.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44H1RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661947295","title":"Edding Genor Expects H1 Net Loss of RMB 60 Million-RMB 70 Million vs Year-Ago Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661947295","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661947295?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:57","pubTimestamp":1787320646,"startTime":"0","endTime":"0","summary":"Edding Genor expects H1 net loss of RMB 60 million-RMB 70 million vs year-ago profitEdding Genor flagged a first-half swing to loss, citing weaker sales, higher R&D spending, and pricing pressure expe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL47Ym1v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295943","title":"Jhbp Cy - Expects Revenue of Rmb850 Mln-Rmb900 Mln for Six Months Ended 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295943?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:57","pubTimestamp":1787320627,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44H1RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1583","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295452","title":"Simcere Pharmaceutical Group (SEHK:2096) Stock Price Trails Margin Surge And DCF Gap","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295452","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295452?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:25","pubTimestamp":1787318740,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group stock has drifted over the past month, down about 9%, even as the latest half year results land with a very different message. The headline is margin power. Net margin for the current period sits at 18% compared with 12.4% a year earlier, and trailing 12 month earnings now reflect a 78.6% yearly jump.\nThe market still prices Simcere Pharmaceutical Group on a P/E of 16.9x, above local pharma peers. However, the company’s own cash flow estimate points to value above...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-sehk2096-stock-price-trails-mar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-sehk2096-stock-price-trails-mar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02096","BK1583","DCF","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":27,"pageCount":21,"totalSize":532,"code":"91000000","status":"200"}]}}